65 related articles for article (PubMed ID: 32559147)
1. The role of microRNA in cisplatin resistance or sensitivity.
Wang S; Li MY; Liu Y; Vlantis AC; Chan JY; Xue L; Hu BG; Yang S; Chen MX; Zhou S; Guo W; Zeng X; Qiu S; van Hasselt CA; Tong MC; Chen GG
Expert Opin Ther Targets; 2020 Sep; 24(9):885-897. PubMed ID: 32559147
[TBL] [Abstract][Full Text] [Related]
2. Autophagy-driven regulation of cisplatin response in human cancers: Exploring molecular and cell death dynamics.
Yang Y; Liu L; Tian Y; Gu M; Wang Y; Ashrafizadeh M; Reza Aref A; Cañadas I; Klionsky DJ; Goel A; Reiter RJ; Wang Y; Tambuwala M; Zou J
Cancer Lett; 2024 Apr; 587():216659. PubMed ID: 38367897
[TBL] [Abstract][Full Text] [Related]
3. Moving beyond cisplatin resistance: mechanisms, challenges, and prospects for overcoming recurrence in clinical cancer therapy.
Fu R; Zhao B; Chen M; Fu X; Zhang Q; Cui Y; Hu X; Zhou W
Med Oncol; 2023 Dec; 41(1):9. PubMed ID: 38063931
[TBL] [Abstract][Full Text] [Related]
4. MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells.
Zangouei AS; Moghbeli M
Genes Environ; 2021 Jun; 43(1):21. PubMed ID: 34099061
[TBL] [Abstract][Full Text] [Related]
5. Research Progress on the Functions and Mechanism of circRNA in Cisplatin Resistance in Tumors.
Mu Q; Lv Y; Luo C; Liu X; Huang C; Xiu Y; Tang L
Front Pharmacol; 2021; 12():709324. PubMed ID: 34566636
[TBL] [Abstract][Full Text] [Related]
6. Proteomics reveals a therapeutic vulnerability via the combined blockade of APE1 and autophagy in lung cancer A549 cells.
Pan ST; Zhou J; Yang F; Zhou SF; Ren T
BMC Cancer; 2020 Jul; 20(1):634. PubMed ID: 32641008
[TBL] [Abstract][Full Text] [Related]
7. LncRNAs and miRNAs participate in determination of sensitivity of cancer cells to cisplatin.
Taheri M; Shoorei H; Tondro Anamag F; Ghafouri-Fard S; Dinger ME
Exp Mol Pathol; 2021 Dec; 123():104602. PubMed ID: 33422487
[TBL] [Abstract][Full Text] [Related]
8. MicroRNAs as Predictors of Lung-Cancer Resistance and Sensitivity to Cisplatin.
Konoshenko M; Lansukhay Y; Krasilnikov S; Laktionov P
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886942
[TBL] [Abstract][Full Text] [Related]
9. Targeting ferroptosis as a potential strategy to overcome the resistance of cisplatin in oral squamous cell carcinoma.
Chen R; Zhu S; Zhao R; Liu W; Jin L; Ren X; He H
Front Pharmacol; 2024; 15():1402514. PubMed ID: 38711989
[TBL] [Abstract][Full Text] [Related]
10. Horizontal transfer of miR-383 sensitise cells to cisplatin by targeting VEGFA-Akt signalling loop.
Raji GR; Poyyakkara A; Sruthi TV; Edatt L; Haritha K; Shankar SS; Kumar VBS
Mol Biol Rep; 2024 Feb; 51(1):286. PubMed ID: 38329638
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic miR-106b-5p promotes cisplatin resistance in triple-negative breast cancer by targeting GDF11.
Zhou Q; Hu Q
Histol Histopathol; 2024 Apr; 39(4):533-541. PubMed ID: 37905957
[TBL] [Abstract][Full Text] [Related]
12. Andrographis modulates cisplatin resistance in lung cancer via miR-155-5p/SIRT1 axis.
Pang C; Zhang T; Chen Y; Yan B; Chen C; Zhang Z; Wang C
Funct Integr Genomics; 2023 Aug; 23(3):260. PubMed ID: 37530871
[TBL] [Abstract][Full Text] [Related]
13. The Role of mTORC1 Pathway and Autophagy in Resistance to Platinum-Based Chemotherapeutics.
Pan Z; Zhang H; Dokudovskaya S
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445831
[TBL] [Abstract][Full Text] [Related]
14. MiR-590-5p promotes cisplatin resistance via targeting hMSH2 in ovarian cancer.
Li B; Xu X; Zheng L; Jiang X; Lin J; Zhang G
Mol Biol Rep; 2023 Aug; 50(8):6819-6827. PubMed ID: 37392283
[TBL] [Abstract][Full Text] [Related]
15. Radiotherapy, Chemotherapy and Immunotherapy-Current Practice and Future Perspectives for Recurrent/Metastatic Oral Cavity Squamous Cell Carcinoma.
Melo-Alvim C; Neves ME; Santos JL; Abrunhosa-Branquinho AN; Barroso T; Costa L; Ribeiro L
Diagnostics (Basel); 2022 Dec; 13(1):. PubMed ID: 36611391
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia induces docetaxel resistance in triple-negative breast cancer via the HIF-1α/miR-494/Survivin signaling pathway.
Li H; Sun X; Li J; Liu W; Pan G; Mao A; Liu J; Zhang Q; Rao L; Xie X; Sheng X
Neoplasia; 2022 Oct; 32():100821. PubMed ID: 35985176
[TBL] [Abstract][Full Text] [Related]
17. Non-SMC condensin I complex subunit H promotes the malignant progression and cisplatin resistance of breast cancer MCF-7 cells.
Liao L; Cheng H; Liu S
Oncol Lett; 2022 Sep; 24(3):317. PubMed ID: 35949592
[TBL] [Abstract][Full Text] [Related]
18. MicroRNAs and Long Non-Coding RNAs in Adrenocortical Carcinoma.
Detomas M; Pivonello C; Pellegrini B; Landwehr LS; Sbiera S; Pivonello R; Ronchi CL; Colao A; Altieri B; De Martino MC
Cells; 2022 Jul; 11(14):. PubMed ID: 35883677
[TBL] [Abstract][Full Text] [Related]
19. Is Autophagy Always a Barrier to Cisplatin Therapy?
Xu J; Gewirtz DA
Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327655
[TBL] [Abstract][Full Text] [Related]
20. Vulnerability of Triple-Negative Breast Cancer to Saponin Formosanin C-Induced Ferroptosis.
Chen HC; Tang HH; Hsu WH; Wu SY; Cheng WH; Wang BY; Su CL
Antioxidants (Basel); 2022 Jan; 11(2):. PubMed ID: 35204181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
